Abstract
Dietary vitamin K is known to influence the anticoagulation response to warfarin. It is possible that dietary vitamin K availability also influences the pharmacological activity of other oral anticoagulants, which target the vitamin-K dependent clotting proteins in the coagulation cascade. This study examined whether vitamin K insufficiency affected anticoagulation response to the direct thrombin inhibitor, ximelagatran. Anticoagulation response to ximelagatran and warfarin in rats on a normal diet was compared to those on a vitamin K deficient diet. Ximelagatran and warfarin increased prothrombin time (PT) by 1.4- and 1.3-fold, activated partial thromboplastin time (APTT) by 1.8- and 1.4-fold and ecarin clotting time (ECT) by 6.8- and 1.2-fold, respectively, in rats on normal diet. Vitamin K deficient diet alone caused modest increases in PT, APTT and ECT. The anticoagulant activity of both ximelagatran and warfarin was significantly greater in rats on vitamin K deficient diet (6.1- and 12.3-fold for PT, 2.6- and 5.1-fold for APTT and 2.9- and 1.6-fold for ECT, respectively) compared to those on normal diet. Factor II activity was reduced by both ximelagatran (58%) and warfarin (44%) in rats on normal diet. However, factor II ...Continue Reading
References
Jun 1, 1991·Journal of Internal Medicine·F M PedersenL Ovesen
Oct 1, 1990·Postgraduate Medical Journal·W H ChowW T Lee
Jan 1, 1988·British Journal of Clinical Pharmacology·I A ChoonaraB K Park
Sep 1, 1993·Journal of Pharmaceutical and Biomedical Analysis·W Naidong, J W Lee
Nov 24, 1999·Nutrition Reviews·S L Booth, M A Centurelli
Feb 1, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Marita LarssonBengt-Arne Persson
Jun 18, 2002·The British Journal of Nutrition·C W ThaneM J Shearer
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ulf G ErikssonDavid Gustafsson
May 14, 2003·Journal of the American College of Cardiology·Palle PetersenUNKNOWN SPORTIF II Investigators
May 14, 2003·European Journal of Clinical Pharmacology·Ulf G ErikssonDavid Gustafsson
Sep 19, 2003·Lancet·Lars WallentinUNKNOWN ESTEEM Investigators
Oct 31, 2003·The New England Journal of Medicine·Charles W FrancisUNKNOWN EXULT A Study Group
Oct 31, 2003·The New England Journal of Medicine·Sam SchulmanUNKNOWN THRIVE III Investigators
Jan 14, 2004·British Journal of Haematology·T KhanF Kamali
Mar 6, 2004·Clinical Pharmacology and Therapeutics·Farhad KamaliHilary Wynne
May 4, 2004·The American Journal of Medicine·Viviane FrancoLuis E Rohde
May 29, 2004·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Stig L BoströmJan-Christer Ulvinge
Jul 3, 2004·Blood·Leon J SchurgersCees Vermeer
Aug 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Laura Y WangAnn Prentice
Nov 30, 2004·Thrombosis Research·Stefan C CarlssonPeter Held
Apr 14, 2005·Nutrition Reviews·Mary Ann Johnson
May 12, 2005·Thrombosis and Haemostasis·Elizabeth SconceFarhad Kamali
Apr 22, 2006·Thrombosis Research·Christopher J Boos, Gregory Y H Lip
Citations
Mar 3, 2009·American Journal of Hematology·Farhad Kamali
Jun 22, 2017·Expert Review of Clinical Pharmacology·Emmanouela Kampouraki, Farhad Kamali
Dec 22, 2020·JBJS Reviews·Luke D HughesCharalambos P Charalambous